Drug Delivery and Biophysics of Biopharmaceuticals
Universitetsparken 2, 2100 København Ø, 13, Building: 13.7.7.07
Degrees and positions in academia
Professor Sven Frokjaer received his MSc (Pharm.) in 1970 and his PhD in physical chemistry in 1973 from the Danish University of Pharmaceutical Sciences. He has been Professor of Pharmaceutics at the Department of Pharmaceutics since 1993 and Rector at the Danish University of Pharmaceutical Sciences from 2003 to 2007.
After the merge with the University of Copenhagen, Sven became Dean at the Faculty of Pharmaceutical Sciences. Since 2012, he is Vice-Dean at the Faculty of Health and Medical Sciences, University of Copenhagen. From 2002 to 2005 he held the position as director of the industrial-oriented graduate research school Drug Research Academy where he his is now chairman of the board.
Before joining the university, Sven Frokjaer spent nearly 20 years at Novo Nordisk A/S involved in research on drug delivery systems and various aspects of peptide and protein formulation.
Today, his primary research interest is focussed on peptide and protein formulation with a special emphasis on particulate drug delivery systems, e.g. microspheres, liposomes and lipid emulsions, and peptide transport across biological membranes including carrier-mediated mechanisms. He has published more 100 scientific papers in these fields.
Sven Frokjaer is a member of several boards and committees including The Danish Pharmacopeia Commission and the Drug Registration Committee under the Danish Health and Medicines Authority. He serves as member of editorial boards on several pharmaceutical journals. He has also served as member at the Danish Medical Research Council for a period of 5 years.
Sven Frokjaer is the co-founder of two biotech companies, Lica Pharmaceuticals A/S and LiPlasome Pharma A/S.